PetVivo’s Spryng Helps Dogs, Cats & Horses Beat Arthritis
For pet owners, veterinarians, and biotech investors: John Lai, CEO of PetVivo (NASDAQ: PETV), and veterinary leader Adam Ainspan share remarkable results from Spryng™ with OsteoCushion™ Technology, a breakthrough injectable for treating osteoarthritis and joint pain in small animals and horses.
From senior dogs regaining mobility to a racehorse returning to competition, Spryng is proving to be a long-lasting, cost-effective, and safer alternative to chronic NSAID use. With benefits lasting up to a year or more per injection, and new tools like the PetVivo AI app on the horizon, PetVivo is changing how veterinarians approach joint health.
💊 Ticker: PETV
🌐 Learn more: petvivo.com
🏷️ Tags
#PetVivo #PETV #Spryng #VeterinaryInnovation #AnimalHealth #PetCare #OsteoarthritisTreatment #DogArthritis #CatHealth #HorseRacing #EquineMedicine #PetOwners #VeterinaryCare #BiotechInvesting #AnimalWellness #PetArthritis #JohnLai #AdamAinspan #PetVivoAI #NewToTheStreet
